T86.02 Bone marrow transplant failure

Name of the Condition

• Bone marrow transplant failure

Summary

Bone marrow transplant failure refers to the inability of a transplanted bone marrow to engraft or function properly, resulting in inadequate hematopoiesis (blood cell production). This condition can occur when the transplanted stem cells fail to establish themselves in the recipient's bone marrow or do not produce sufficient blood cells, leading to persistent cytopenias (low blood cell counts) or other complications.

Causes

Failure may result from inadequate stem cell dose, poor graft quality, or recipient factors such as extensive prior chemotherapy, radiation damage, or immunological barriers. Technical issues during transplantation, including improper cell handling or infusion, can also contribute. In some cases, the transplanted cells may be rejected by the recipient's immune system.

Risk Factors

• Prior intensive chemotherapy or radiation therapy
• Advanced age or poor overall health
• Mismatched donor-recipient human leukocyte antigen (HLA) typing
• Low stem cell dose or poor graft viability
• Underlying bone marrow fibrosis or damage
• Immune-mediated rejection of the graft

Symptoms

• Persistent or worsening cytopenias (anemia, thrombocytopenia, neutropenia)
• Fatigue, weakness, or shortness of breath (due to anemia)
• Increased risk of infections (due to neutropenia)
• Unusual bleeding or bruising (due to thrombocytopenia)
• Fever or signs of infection
• Delayed or absent engraftment (e.g., no rise in blood counts post-transplant)

Diagnosis

Diagnosis involves monitoring blood counts over time to assess engraftment, bone marrow biopsies to evaluate cellularity and graft presence, and flow cytometry or chimerism testing to confirm donor cell engraftment. Additional tests may include assessing for immune rejection or graft-versus-host disease (GVHD) if present.

Treatment Options

• Supportive care (e.g., transfusions, antibiotics) to manage cytopenias and infections
• Second bone marrow transplant (if feasible)
• Growth factor administration to stimulate hematopoiesis
• Immunosuppressive therapy to address rejection
• Investigational therapies or clinical trial participation in refractory cases

Prognosis and Follow-Up

Prognosis depends on the underlying cause, timing of failure, and response to treatment. Early detection and intervention improve outcomes. Follow-up includes regular blood count monitoring, bone marrow assessments, and management of complications like infections or GVHD. Long-term surveillance is necessary to detect late effects.

Complications

• Severe or life-threatening infections due to prolonged neutropenia
• Bleeding disorders from thrombocytopenia
• Organ damage from persistent anemia
• Graft-versus-host disease (if allogeneic transplant)
• Need for additional transplants or alternative therapies

Lifestyle & Prevention

• Adherence to post-transplant care plans, including medication regimens
• Prompt reporting of symptoms like fever or bleeding
• Avoidance of infections (e.g., hand hygiene, avoiding sick contacts)
• Nutritional support to maintain overall health
• Regular follow-up with the transplant team

When to Seek Professional Help

Seek immediate medical attention for:

• Fever (especially with neutropenia)
• Unusual bleeding or bruising
• Shortness of breath or severe fatigue
• Signs of infection (e.g., chills, cough, diarrhea)
• Persistent or worsening blood count abnormalities

Tips for Medical Coders

Document the timing of failure (e.g., primary graft failure vs. secondary graft failure), underlying causes (if known), and any interventions. Include details on engraftment status, blood count trends, and biopsy results to support coding. Ensure documentation aligns with clinical findings and reflects the severity of hematopoietic dysfunction.